WHO ICTRP trial
The aim of this study is to see how well an investigational drug (called…
EUCTR2016-002718-32-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-002718-32-IT |
|---|---|
| Public title | The aim of this study is to see how well an investigational drug (called BBI-608) works when it is given in combination with paclitaxel, a chemotherapy treatment, or if it is better to receive paclitaxel alone for people with advanced, previously treated lung cancer. To do so, half of the patients in this study will receive paclitaxel plus BBI-608 while the other half will receive paclitaxel alone. |
| Scientific title | A Phase III Randomized, Open-Label Clinical Trial of BBI-608 plus Weekly Paclitaxel versus Weekly Paclitaxel Alone in Patients with Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer - - |
| Primary sponsor | BOSTON BIOMEDICAL, INC. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Czechia;Spain;Israel;United Kingdom;Italy;France;Hungary;Canada;Poland;Belgium;Australia;Netherlands;Germany;China;Japan;Korea, Republic of |
| Conditions | Histologically or cytologically confirmed recurrent, locally advanced, or metastatic non-squamous non-small cell lung cancer. MedDRA version: 21.1 Level: LLT Classification code 10066490 Term: Progression of non-small cell lung cancer… |
| Interventions | Product Name: BBI-608 (napabucasin) Product Code: BBI-608 Pharmaceutical Form: Capsule, hard INN or Proposed INN: Napabucasin CAS Number: 83280-65-3 Current Sponsor code: - Other descriptive name: NAPABUCASIN, BBI-608, BBI608, BB608… |
| Registration date | Jan 20, 2021 |
| Target size | 870 |
| Secondary IDs | CanStem43L;NCT02826161;2016-002718-32-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: